Objective: We present a case series of acute vulvar aphthosis immediately following COVID-19 vaccination.
Materials And Methods: We describe 3 cases of acute vulvar aphthosis following Pfizer Comirnaty BNT162b2 mRNA and AstraZeneca (Vaxzevria) ChAdOx1 nCoV-19 COVID-19 vaccination in adolescent girls.
Results: All patients developed vulvar aphthosis within a few days after receiving COVID-19 vaccination.